Top Markets
#1 Official Trump Official Trump +37.23%
#2 Siacoin Siacoin +22.82%
#3 Melania Meme Melania Meme +20.04%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.89%
#5 Pump.fun Pump.fun +19.64%
#6 Unit Pump Unit Pump +19.64%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.56%
#9 Wrapped POL Wrapped POL +17.44%
#10 Mubarak Mubarak +17.31%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rank in Stocks #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Share Price
$20.65
Last synced: 2023-03-01
Market Cap
$82.52M
Change (1 day)
-0.58%
Change (1 year)
0.00%
Country
US
Trade Opiant Pharmaceuticals, Inc. (OPNT)

Category

Healthcare
Number of shares outstanding for Opiant Pharmaceuticals, Inc. (OPNT)
Number of shares outstanding as of August 2026: 0
According to Opiant Pharmaceuticals, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Opiant Pharmaceuticals, Inc. (OPNT) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH